Olivier Keller
Overview
Explore the profile of Olivier Keller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
39
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzo-Villalba N, Zulfiqar A, Auburtin M, Schuhmacher M, Meyer A, Maouche Y, et al.
Eur J Case Rep Intern Med
. 2020 Jun;
7(6):001702.
PMID: 32523922
Learning Points: Immune thrombocytopenia should be considered in COVID-19-infected patients presenting with thrombocytopenia.Coronavirus-related thrombocytopenia can be severe and life-threatening.Despite the severity of coronavirus-related immune thrombocytopenia, recovery may be spontaneous or...
2.
Andres E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Severac F, et al.
J Clin Med
. 2017 Sep;
6(10).
PMID: 28954408
Background: Despite major advances in its prevention and treatment, febrile neutropenia remains a most concerning complication of cancer chemotherapy. Outside the oncology setting, however, only few data are currently available...
3.
Andres E, Mourot-Cottet R, Maloisel F, Severac F, Keller O, Vogel T, et al.
QJM
. 2017 Jan;
110(5):299-305.
PMID: 28069912
Backgroud: Few data is currently available on neutropenia and agranulocytosis related to drug intake. We report here data on 203 patients with established idiosyncratic drug-induced agranulocytosis, followed up in a...
4.
Mourot-Cottet R, Maloisel F, Severac F, Keller O, Vogel T, Tebacher M, et al.
Drugs Real World Outcomes
. 2016 Oct;
3(4):393-399.
PMID: 27747601
Background: Little data is currently available in the literature on neutropenia and agranulocytosis in the elderly, and, to our knowledge, idiosyncratic drug-induced agranulocytosis is particularly poorly covered, or not at...